SCHEMBL56766

SCHEMBL56766

CC(C)([C]=O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL961645 0.73
SCHEMBL2190608 0.71
SCHEMBL270202 0.69
SCHEMBL9058110 0.69
SCHEMBL16208243 0.69
SCHEMBL7346515 0.67
SCHEMBL116713 0.67
SCHEMBL9021368 0.67
SCHEMBL1267481 0.67
SCHEMBL1266944 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 274 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4061868-A1 COPOLYESTERS FOR USE IN LOW SHEAR MELT APPLICATIONS Eastman Chemical Company (US) 2022-09-28 EP claimed
WO-2021102129-A1 COPOLYESTERS FOR USE IN LOW SHEAR MELT APPLICATIONS EASTMAN CHEMICAL COMPANY (US) 2021-05-27 WO claimed
EP-3298063-A1 ALIPHATIC POLYESTER COATING COMPOSITIONS CONTAINING TETRAMETHYL CYCLOBUTANEDIOL Eastman Chemical Company (US) 2018-03-28 EP claimed
WO-2016187095-A1 ALIPHATIC POLYESTER COATING COMPOSITIONS CONTAINING TETRAMETHYL CYCLOBUTANEDIOL EASTMAN CHEMICAL COMPANY (US) 2016-11-24 WO claimed
US-20140309192-A1 MODULATORS OF THE G PROTEIN-COUPLED MAS RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC, 2014-10-16 US claimed
EP-2776407-A1 MODULATORS OF THE G PROTEIN-COUPLED MAS RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2014-09-17 EP claimed
WO-2014087184-A1 NEOPENTYL GLYCOL FERMENTATIVE PRODUCTION BY A RECOMBINANT MICROORGANISM METABOLIC EXPLORER (FR) 2014-06-12 WO claimed
WO-2013070657-A1 MODULATORS OF THE G PROTEIN-COUPLED MAS RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2013-05-16 WO claimed
US-8163773-B2 Organic compounds NOVARTIS AG (CH) 2012-04-24 US claimed
US-7879852-B2 such as (4S)-1-{[(3S,4R)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidine-3-yl]carbonyl}-4-[(4,4-dimethylcyclohexyl)(2,2-dimethylpropanoyl)amino]-N,N-dimethyl-L-prolineamide, used for the treatment of obesity, diabetes, inflammation and erectile dysfunction LG LIFE SCIENCES LTD. (KR) 2011-02-01 US claimed
WO-2008007930-A1 MELANOCORTIN RECEPTOR AGONISTS LG LIFE SCIENCES LTD. (KR) 2008-01-17 WO claimed
WO-2007077005-A1 3 , 5-SUBSTITΓUED PIPERIDINE COMPOUNDS AS RENIN INHIBITORS NOVARTIS AG (CH) 2007-07-12 WO claimed
WO-2007006534-A2 PIPERIDINE DERIVATIVES USEFUL IN THE DIAGNOSTIC AND THERAPEUTIC TREATMENT OF DISEASES DEPENDING ON RENIN ACTIVITY NOVARTIS AG (CH) 2007-01-18 WO claimed
EP-1131372-B1 UNSATURATED POLYESTER RESINS ASHLAND INC (US) 2006-06-14 EP claimed
EP-1131372-A1 UNSATURATED POLYESTER RESINS Dynea Chemicals OY (FI) 2001-09-12 EP claimed
US-6156752-A Optically active 1,4-dihydropyridine compounds as bradykinin antagonists PFIZER INC (US) 2000-12-05 US claimed
WO-2000023495-A1 UNSATURATED POLYESTER RESINS DYNEA CHEMICALS OY (FI) 2000-04-27 WO claimed
EP-0899261-A1 Optical active 1,4-dihydropyridine compounds as bradykinin antagonists PFIZER INC. (US) 1999-03-03 EP claimed
WO-1995014053-A1 WATER-DISSIPATABLE ALKYD RESINS AND COATINGS PREPARED THEREFROM EASTMAN CHEMICAL COMPANY (US) 1995-05-26 WO claimed
US-5378757-A Containing sulfonate groups EASTMAN CHEMICAL COMPANY (US) 1995-01-03 US claimed